Balwan Singh has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Ram Dayal

    Sunder Deep Pharmacy College, India

    3 shared publications
  • Akshay Verma

    KIET School of Pharmacy, Krishna Institute of Engineering & Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India

    2 shared publications
  • Jatin Pachera

    KIET School of Pharmacy, Krishna Institute of Engineering & Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India

    2 shared publications
  • Shardendu Kumar Mishra

    KIET School of Pharmacy, Krishna Institute of Engineering & Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India

    2 shared publications
  • Afzal Khan

    1 shared publication
  • Akshat Shandilya

    KIET School of Pharmacy, Krishna Institute of Engineering & Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India-201206

    1 shared publication

Latest Publications

  • Integrating Nanotechnology and Phytomedicine for Hepatic Disease Treatment

    by Balwan Singh, Ram Dayal, Harsh Grewal, Astha Tyagi, Shahid Karim

    Nanotechnology offers a new strategy for combining plant-based therapy for liver disease. The properties of a nanoscale material, a nanomaterial, are special and may be able to promote and nourish damaged hepatocytes in a less invasive manner than surgery or transplantation, and convert into new tissue in the body. Nano-sized drugs enhance the cure of liver diseases by enhancing drug bioavailability, drug distribution targeting, and drug release control. This is especially critical for resolving issues such as low solubility and rapid degradation of phytochemicals. There are many bioactive compounds in phytomedicine. This type of medicine can shield the liver and prevent inflammation, making it a natural way to fight liver diseases. Liver-specific ligands can be crafted based on the efficacy of the uplift-and attrition effect, with the passive aspect of the targeting principle. Having such a precise way of delivering, one can predict fewer side effects in the body and a higher level of effect, that is to say. An example is fatty liver disease. Nanocarriers loaded with antioxidants have the potential of mitigating oxidative stress. In cirrhosis, anti-fibrotic drugs may prevent hepatic stellate cells from producing too many collagen fibres and other substances to stiffen the liver tissue to the point of ultimately killing a patient.

  • Development and Characterization of Solid Dispersions of Amitriptyline Hydrochloride for Enhanced Solubility and Dissolution Performance

    by Ashutosh Pathak, Balwan Singh, Anuj Pathak, Kartik Sharma, Dev Tyagi, Varshit Tyagi

    A common tricyclic antidepressant used to treat major depressive disorders, neuropathic pain, migraine prevention, and a number of chronic pain diseases is amitriptyline hydrochloride. The drug's pH-dependent solubility and restricted water solubility under intestinal circumstances can negatively impact its dissolving rate and oral bioavailability, notwithstanding its therapeutic efficacy. The goal of the current work was to improve amitriptyline hydrochloride's solubility and dissolution properties by creating polymer-based solid dispersion systems that use hydrophilic carriers. To determine the best carrier system for enhancing the drug's physicochemical performance, solid dispersions were made using the solvent evaporation approach with various polymers and drug-to-polymer ratios. To assess the impact of various polymers on drug solubilization, saturation solubility studies were first carried out. Solid-state analytical methods and dissolving tests were used to further characterize the produced formulations. HPMC-AS-based solid dispersions outperformed alternative carrier systems among the formulations under investigation. With a drug-to-polymer ratio of 1:3, the improved formulation, known as SDO3, showed the greatest improvement in solubility and dissolving behavior. The pure drug's saturation solubility was 0.31 ± 0.02 mg/mL, while SD-O3's was 3.68 ± 0.14 mg/mL, a twelve-fold improvement. According to dissolution trials, the improved solid dispersion obtained 96.8 ± 2.2% drug release in 60 minutes, while the pure drug only released 32.4 ± 2.1%. The physical mixture only slightly improved, suggesting that the creation of a real solid dispersion system rather than straightforward carrier-mediated wetting effects was the main cause of SD-O3's improved performance. A thorough solid-state characterisation was carried out to look into the mechanism causing the enhancement of disintegration. FTIR confirmed the presence of amitriptyline hydrochloride in the HPMC-AS formulation‚ and indicated that no meaningful chemical interactions or degradation occurred during the formulation process․ DSC analysis showed that the melting endotherm of amitriptyline hydrochloride‚ which was present in the crystalline form‚ was not detectable in the new formulation‚ indicating a successful transition to the amorphous state․ PXRD studies confirmed that the formation of an amorphous molecular dispersion in the polymeric carrier had been successfully achieved due to the absence of all crystalline diffraction peaks of the SD-O3 formulation․ The improved dissolution behavior could be attributed to the lower crystallinity‚ larger surface area‚ better wettability‚ molecular-level dispersion of drug in polymeric carrier‚ as well as stabilization ofthe amorphous state by HPMC-AS․ Thus‚ HPMC-AS based solid dispersion using solvent evaporation method is a successful approach to overcome the solubility issue of Amitriptyline Hydrochloride․ The formulated system may be contemplated as a promising strategy to improve oral bioavailability and therapeutic potential of water insoluble drugs due to substantial enhancement in solubility and in vitro dissolution․

  • Deferasirox Analytical Profiling through Analytical Method Development and Analytical Method Validation

    by Akshat Shandilya, Surbhi Kamboj, Sheena Mehta, Balwan Singh

    Deferasirox, a regular oral iron chelator used to treat transfusion-related iron overload among people with chronic anaemias like beta thalassaemia. The drug's tridentate ligand structure helps it to bind ferric iron (Fe³⁺) with notable selectivity, making a stable 2:1 complex. It is not yet listed in official pharmacopoeias while being clinically significant. In this work, we define a validated analytical technique that uses high performance liquid chromatography (HPLC) with UV detection to predict deferasirox plasma concentrations. With a 10-minute run time and 248 nm monitoring chromatographic separation happened on C18 reverse phase column, offering a dependable and recurring method for measurement. The developed RP-HPLC method was found to be robust, rapid, and reliable for the analysis of Deferasirox with a retention time of 2.2 min. The method utilized green/eco-friendly solvent conditions with reduced chemical consumption, making it suitable for routine pharmaceutical analysis.

  • Synergistic Wound-Healing Potential of Green Tea and Rosemary Bioactives: Insights from Network Pharmacology and Molecular Docking

    by Jatin Pachera, Akshay Verma, Balwan Singh, Shardendu Kumar Mishra

    Wound healing represents a highly coordinated biological sequence that encompasses inflammation, cellular proliferation, and tissue remodeling, all working together to repair and restore the integrity of damaged skin. Disturbances in immune response, infection, and oxidative stress delay healing. Plant-derived phytochemicals such as those from green tea and rosemary may enhance healing by targeting multiple molecular pathways simultaneously. Active compounds of polyherbal preparation were collected from literature databases and screened for ADMET and drug-likeness using SwissADME. SwissTargetPrediction helped forecast potential targets for these compounds, while GeneCards supplied the wound healing-related genes. Venny 2.1 then flagged the overlapping targets between drug effects and disease genes. From there, we built a PPI network in STRING and dug into it with Cytoscape to spot hub genes, followed by GO and KEGG analysis to map out key functions and pathways. Finally, molecular docking was carried out between key phytochemicals and core wound-healing targets to evaluate binding affinity. 8 major bioactive compounds were identified from green tea and rosemary. Target prediction yielded 481 potential drug targets, while 7,101 wound-healing–related genes were retrieved from GeneCards. Intersecting analysis identified 262 common targets. PPI network analysis revealed 10 hub genes (IL6, HIF1A, EGFR, TP53, TNF, SRC, ESR1, CASP3, PPARG, BCL2). GO enrichment indicated involvement in inflammation, cell proliferation, and re-epithelialization. KEGG analysis highlighted the MAPK signaling pathway as the most prominent pathway related to wound healing. Molecular docking studies revealed robust binding affinities for key compounds-including rosmarinic acid, ursolic acid, carnosic acid, carnosol, EGCG, ECG, catechin and EGC-with pivotal targets like IL-6, TP53, EGFR, TNF and SRC, therby bolstering their promise in promoting wound healing. The findings from this study lay a solid groundwork for deeper exploration into the wound-healing compounds and pathways in green tea and rosemary, while offering a scientific rationale for developing novel therapeutics agents derived from their bioactive phytochemicals.

  • Oral Acute Toxicity Study and Anti-Urolithiatic Activity of Schleichera Oleosa Bark Extract Against Ethylene Glycol- Induced Urolithiasis in Male Wistar Rats

    by Akshay Verma, Jatin Pachera, Balwan Singh, Deepali Pandey, Shardendu Kumar Mishra

    Urolithiasis, particularly calcium oxalate nephrolithiasis, remains a prevalent global urinary disorder with high recurrence. Current therapies primarily focus on symptomatic relief and surgical removal, often accompanied by adverse effects and high relapse rates. Medicinal plants such as Schleichera oleosa possess anti-inflammatory and antioxidant activity was already reported. This study supports Schleichera oleosa bark extract having potential action against Antiurolithiatic activity. Quantitative phytochemical analysis of Schleichera oleosa bark extract was conducted to determine the main bioactive compounds such as TPC, TFC, TAC, TTC by spectrophotometric methods. Schleichera oleosa bark extract oral toxicity was conducted by the OECD TG 423. To investigate the potential toxicity of Schleichera oleosa bark extract against urolithiasis. Schleichera oleosa was administered orally to Wistar Rat at various dose level 5, 50, 300 & 2000 mg/kg & closely examine for further 14 days to evaluate any mortality and any delay toxic effect. Ethylene glycol induced lithiasis in Wistar rat model by taking 36 animals dividing into six cohorts; G-I Vehicle control, G-1 Disease control, G-III standard (cystone750mg/kg)), G-IV Schleichera oleosa low concentration (50 mg/kg), G-V Schleichera oleosa medium concentration (100 mg/kg), G-VI Schleichera oleosa high concentration (200 mg/kg) & 0.75%v/v ethylene glycol is received to all animal except vehicle control group. In conclusion, the Schleichera oleosa extract exhibited promising anti-urolithiasis activity in the animal ethylene glycol model and may represent a potential alternative therapeutic approach for the management of urolithiasis. Further investigation, are recommended to identify the pharmacokinetics study and to validate their efficacy through advanced preclinical and clinical investigations.

  • Open Access

    Phytopharmacological Insights into Ricinus communis: A Comprehensive Overview

    by Surya Nath Pandey, Prashant Kumar, Harishchandra Verma, Sumit Durgapal, Balwan Singh

    Medicinal plants are used in the traditional medicinal system and in Ayurveda globally. Euphorbiaceae is a large family which contains more than 3000 species. Ricinus communis or castor bean plant is well-known plant of Ayurveda. The herbal and natural medicines are the cost-effective and they have lesser side effects than currently available medicines in the market. Ricinus communis has many phytoconstituents such as ricinine, ricin A, ricin B, ricin C, ricinoleic acid, Y-sitosterol, fucosterol, stigmasterol, ricinus agglutin etc. which are responsible for various pharmacological activities. Traditionally, it has various pharmacological properties such as antioxidant activity, antifertility activity, antiulcer activity, antidiabetic activity, antimicrobial activity, hepatoprotective activity, immunomodulatory activity, bone regeneration activity, cytotoxic activity, anti-inflammatory activity etc. They also exhibited free radical scavenging potential along with repellent properties. The main objective of this review is to reveal all updated information's like phytochemicals, pharmacological activities of Ricinus communis by scientific evidences.


  • QbD-Driven Development and Evaluation of EGCG-Loaded Transfersomal Gel for Non-Melanoma Skin Carcinoma

    by Balwan Singh, Nanda S

    The most common type of cancer is non-melanoma skin cancer (NMSC), necessitating the development of non-invasive and novel method of treatment. The current research study is focused on the design, development, and evaluation of a transfersomal gel loaded with epigallocatechin-3-gallate (EGCG), a bioactive compound with significant anti-cancer properties. After establishing anticancer properties of EGCG using cell lines and in silico studies, transfersomes were formulated using Box-Behnken Design (BBD). Optimization was done with three factors and three levels The optimized transfersomal gel exhibited significant physicochemical characteristics. Smaller V.S., improved Z.P. and high EE facilitated enhanced skin penetration as proved by in vitro and ex vivo studies using porcine skin. These findings demonstrated the potential of transfersomal formulation in enhancing the transdermal delivery of EGCG, paving the way for effective approaches for managing non-melanoma skin cancer. Further, clinical studies can enhance the potential and application of this bioactive molecule.

  • Open Access

    Assessing the Protective Effects of PC-1 Formulation on Ethanol-Induced Gastric Ulcer Model in Wistar Rats: A Comprehensive Study

    by Vijul Kumar Choudhary, Shardendu Kumar Mishra, Garima Kapoor, Shubham Chaudhary, Roma Ghai, Balwan Singh, Monika Kaurav

    The PC-1 formulation, renowned for its diverse biological properties, has yet to be thoroughly examined for its effects on stomach ulceration. Acute toxicity assessment of a lower dose (1000 mg/kg) of PC-1 formulation did not exhibit any observable signs of toxicity, suggesting its potential as protective mediator in contrast to stomach epithelial mutilation. The omeprazole group received 30 mg/kg omeprazole orally. The investigational groups were orally gavage with PC-1 extract formulation at dosage 50mg/kg, 100mg/kg, and 200mg/kg in (1%) CMC. Subsequently, after an hour, the normal group received normal water via gavage, while groups 2–6 were administered absolute ethanol via gavage. Treatment with PC-1 extract formulation significantly mitigated ethanol-induced gastric injuries, as demonstrated through improved gastric mucus secretion, pH levels, reduced ulceration size, and decreased infiltration of leukocytes in submucosal layer. Analysis of stomach epithelial homogenate revealed a significant upsurge in the superoxide dismutase, catalase, and glutathione, along with a notable decrease in malondialdehyde (MDA) levels upon treatment with PC-1 formulation. The observed gastroprotective effects of PC-1 formulation could be attributed to its capacity to improve pH and mucus secretion, elevate SOD, GSH, and CAT levels, while reducing MDA levels.

  • Open Access

    Comparison Study of Aloin-Curcumin Nanoparticles by Taking 2 Different Ratios and Analyses by Using Drug Design Experimental Study.

    by Rishika . Chauhan, Balwan . Singh, Ram . Dayal, Anuj Malik . Malik

    Numerous chemopreventive drugs like aloin and curcumin have demonstrated potential effects in cancer treatment; however, their efficacy is limited by low bioavailability. Thus, the primary goal of this research was to formulate a unique method by using the herbal drugs synergistically and improve the bioavailability of these anticancer drugs here, using the nanoprecipitation method for two well-active constituents of known natural herbal compounds. Aloin (AL)-curcumin (CUR) were co-loaded into polymeric nanoparticles made of poly (D, L-lactide-co-glycolide) and surfactant-polyvinyl alcohol, with the experiment’s response being evaluated using Stat-Ease software. To create dual-loaded nanoparticles containing aloin and curcumin, using different ratios sand optimizing the best formulation. (60:120). For aloin curcumin, optimize the better formulation with controlled release formulation having less than 100 nm size of particle and drug entrapment was 86.09% while for (60:60) of aloin -curcumin having 99.1 nm particle size of drug and encapsulation efficiency was 72.05%.